High-Risk Prostate Cancer Treatment - MUSC Hollings

preview_player
Показать описание
David T. Marshall, M.D., is a board-certified radiation oncologist, specializing in genitourinary and gastrointestinal cancers at MUSC Hollings Cancer Center in Charleston, SC. In this informative video he shares educational information for patients on high-risk prostate cancer treatment.
  1. MUSC Health
  2. prostate cancer
  3. high risk
  4. marshall
  5. musc
  6. hollings cancer center
Рекомендации по теме
High-Risk Prostate Cancer 0:20:29

High-Risk Prostate Cancer Treatment - MUSC Hollings

Treatment recommendations for 0:02:50

Treatment recommendations for high-risk biochemical recurrent prostate cancer

Treating High-Risk Gleason 0:10:55

Treating High-Risk Gleason 8: A Modern Approach | Mark Scholz, MD | PCRI

High Risk Prostate 0:09:32

High Risk Prostate Cancer: Surgery vs. Radiation | Genomic Tests | Mark Scholz, MD | PCRI

Dr. Nguyen on 0:01:22

Dr. Nguyen on Treatment Considerations in High-Risk Prostate Cancer

The role of 0:02:44

The role of radiation in managing high-risk localized prostate cancer

Unorthodox Treatments for 0:05:50

Unorthodox Treatments for High-Risk Prostate Cancer | Prostate Cancer Staging Guide

Dr. Kearns on 0:01:12

Dr. Kearns on the Role of Surgery in High-Risk Prostate Cancer

Staging Intermediate- and 0:06:17

Staging Intermediate- and High-risk Prostate Cancer With 18F PSMA/PET/CT vs MRI

High-Risk Prostate Cancer: 0:05:54

High-Risk Prostate Cancer: Benefit to adding 2nd Generation Hormone Therapy or Chemo? | PCRI

Treatment for Low 0:06:40

Treatment for Low and Basic Azure (High-Risk) Prostate Cancer | Prostate Cancer Staging Guide

Hormone Therapy & 0:19:08

Hormone Therapy & Side Effects For High-Risk (Gleason 8) #ProstateCancer | Mark Scholz, MD #PCRI

Gleason 9 & 0:11:36

Gleason 9 & 10 Prostate Cancer: Cure Rates, Treatments, New Approaches | Mark Scholz, MD | PCRI

Staging and Treatment 0:02:18

Staging and Treatment of Unfavorable Intermediate or High-Risk Prostate Cancer

Localized high-risk prostate 0:01:17

Localized high-risk prostate cancer: updated results from 12-year follow up of GETUG-12

Dr. Nguyen on 0:01:53

Dr. Nguyen on the Optimal Duration of ADT in High-Risk Prostate Cancer

Debate: Surgery vs. 0:09:44

Debate: Surgery vs. Brachytherapy for Intermediate and High-Risk Prostate Cancer - Surgery

Neoadjuvant androgen deprivation 0:11:22

Neoadjuvant androgen deprivation therapy in men with high-risk localized prostate cancer

Updates on the 0:01:51

Updates on the treatment landscape of high-risk localized prostate cancer

NCCN Guidelines for 0:07:50

NCCN Guidelines for Treatment of Localized Prostate Cancer

Survivorship in high 0:04:23

Survivorship in high risk localized prostate cancer

Evaluation of a 0:04:56

Evaluation of a High-Risk Prostate Cancer Patient

High-risk Prostate Cancer 0:03:30

High-risk Prostate Cancer Clinic

Therapy Approach in 0:03:22

Therapy Approach in High-Risk Prostate Cancer